Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220148 · ClinicalTrials.gov registry record · NA
Multimodal Immune and Neuroendocrine Assessment in Drinkers
A NA study, sponsored by Auburn University.
- Not yet
- Registry status
- NA
- Development phase
- 234
- Enrollment target
NCT07220148: Clinical Trial NA study, sponsored by Auburn University.
NCT07220148 is a NA study that has not yet begun recruiting, run by Auburn University. The registered enrollment target is 234 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07220148, a NA study, has not yet begun recruiting, sponsored by Auburn University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 234 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to better understand how blood flow in the brain, levels of the hormone, cortisol, and levels of an immune factor, interleukin-6, change in response to pictures of alcohol versus water pictures of water in healthy people who regularly consume alcohol. Researchers will learn about how the brain processes our environment and how it relates to people's drinking behaviors. This information is important because it may allow us to develop new treatments for Alcohol Use Disorders. Participants will be asked to fill out psychological questionnaires at the first appointment. Then, they will do MRI scans with blood draws at visits 2-6. After each MRI scan, participants will undergo the Alcohol Taste Test, which involves drinking beer. There will be a total of 3 visits at baseline, 2 visits one year later, and 2 visits one year after that. Each visit will last 2 hours. Each year, participants will do 21 days of surveys on a smart phone (4 surveys a day; each survey takes less than 2 minutes). The total time commitment for the entire study will be 23 hours.
Primary Outcome
Change in blood-oxygen-level dependent (BOLD) activation to alcohol versus neutral cues in regions of interest (e.g., medial prefrontal cortex, posterior cingulate cortex, striatum) measured using 7 Tesla functional MRI.
Interventions
- BEHAVIORAL Alcohol Cue Reactivity and Laboratory Alcohol Administration Paradigm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2026-04 |
| Est. Completion | 2031-12 |
| Phase | NA |
What is known before NCT07220148 opens enrollment
NCT07220148 is an interventional study that assigns participants to a tested intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Alcohol Cue Reactivity and Laboratory Alcohol Administration Paradigm is the first listed.
NCT07220148 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07220148 about?
NCT07220148 is a clinical study titled "Multimodal Immune and Neuroendocrine Assessment in Drinkers". The goal of this clinical trial is to better understand how blood flow in the brain, levels of the hormone, cortisol, and levels of an immune factor, interleukin-6, change in response to pictures of alcohol versus water pictures of water in healthy people who regularly consume alcohol. Researchers w...
What is the current status of trial NCT07220148?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 234 participants. The study started on 2026-04. Estimated completion is 2031-12.
What interventions are being tested in trial NCT07220148?
The interventions under investigation include: Alcohol Cue Reactivity and Laboratory Alcohol Administration Paradigm (BEHAVIORAL).
Who is sponsoring clinical trial NCT07220148?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07220148's enrollment target sits among peer trials
234 462nd of 2000 higher than 1,538 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
- NCT05444465 · 234 participants · NA
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
- NCT05720338 · 234 participants · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia